Literature DB >> 7498265

Capsaicin pre-treatment prevents the development of antigen-induced airway hyperresponsiveness in neonatally immunised rabbits.

C M Herd1, N Gozzard, C P Page.   

Abstract

The effect of a 3-day pre-treatment regime of capsaicin (8-methyl-N-vanillyl-6-nonenamide) (80 mg/kg s.c.) on airway changes induced by Alternaria tenuis aerosol challenge 3 days later was assessed in adult rabbits immunised from birth to the age of 3 months. Pre-treatment with capsaicin did not alter basal lung function or basal responsiveness to inhaled histamine. While capsaicin had no significant effect on the acute bronchoconstriction induced by antigen, this dose was sufficient to significantly inhibit the increase in airway responsiveness to inhaled histamine achieved 24 h following antigen challenge. The pulmonary recruitment of neutrophils and eosinophils induced by antigen was unaltered by prior treatment with capsaicin. In vitro contractile responsiveness to methacholine was not significantly different in bronchial tissues removed from capsaicin- and vehicle-pre-treated rabbits. In addition, there were no significant differences in responses to methacholine in preparations denuded of epithelium. Contraction of bronchial tissue induced by exogenously applied capsaicin in vitro, although modest, was significantly inhibited in capsaicin-pre-treated animals. In vehicle-pre-treated rabbits, contraction induced by a second challenge with capsaicin 45 min later was significantly reduced to a level that made responses not significantly different from those obtained in capsaicin-pre-treated tissues. The results of the present study demonstrate that antigen-induced airway hyperresponsiveness to inhaled histamine in immunised rabbits is inhibited by prior treatment with capsaicin. These findings suggest the involvement of capsaicin-sensitive nerves in antigen-induced airway hyperresponsiveness but not acute bronchospasm or cell infiltration induced by antigen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498265     DOI: 10.1016/0014-2999(95)00291-r

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  TRPV1: on the road to pain relief.

Authors:  Andrés Jara-Oseguera; Sidney A Simon; Tamara Rosenbaum
Journal:  Curr Mol Pharmacol       Date:  2008-11       Impact factor: 3.339

2.  Effect of heparin on antigen-induced airway responses and pulmonary leukocyte accumulation in neonatally immunized rabbits.

Authors:  J M Preuss; C P Page
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor.

Authors:  M Holbrook; N Gozzard; T James; G Higgs; B Hughes
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

4.  Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunised rabbits.

Authors:  N Gozzard; A el-Hashim; C M Herd; S M Blake; M Holbrook; B Hughes; G A Higgs; C P Page
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

5.  Effects of theophylline and rolipram on antigen-induced airway responses in neonatally immunized rabbits.

Authors:  N Gozzard; C M Herd; S M Blake; M Holbrook; B Hughes; G A Higgs; C P Page
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

Review 6.  TRP channels in airway sensory nerves.

Authors:  Qihai Gu; Lu-Yuan Lee
Journal:  Neurosci Lett       Date:  2021-02-12       Impact factor: 3.046

7.  Lack of desensitization of the cough reflex in ovalbumin-sensitized rabbits during exercise.

Authors:  Angelica Tiotiu; Bruno Chenuel; Laurent Foucaud; Bruno Demoulin; Silvia Demoulin-Alexikova; Christo Christov; Mathias Poussel
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

Review 8.  Sensory nerves and airway irritability.

Authors:  B J Canning; D Spina
Journal:  Handb Exp Pharmacol       Date:  2009
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.